MIRA
MIRA Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Other
- Website mirapharmaceuticals.com
- Employees(FY) -
- ISIN US60458C1045
Performance
-12.67%
1W
-17.09%
1M
-37.02%
3M
-80.62%
6M
-37.62%
YTD
-91.17%
1Y
Profile
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Technical Analysis of MIRA 2024-05-10
Overview:
In analyzing the technical indicators for MIRA stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and recommendations for pot...
Recent News & Updates
- 2024-05-13 09:53
- 2024-04-01 20:00
- 2024-04-01 02:53
- 2024-03-20 23:04
- 2024-03-07 19:19
Why Is Mira Pharmaceuticals (MIRA) Stock Up 52% Today?(Investorplace)
- 2024-02-04 19:30
MIRA Pharmaceuticals Provides Corporate Update(Prnewswire)
- 2023-12-03 19:00
- 2023-11-28 19:00
- 2023-11-20 21:42
- 2023-11-20 21:09
- 2023-11-19 19:00
- 2023-10-25 19:23
- 2023-09-17 20:30
- 2023-09-04 20:31
- 2023-08-30 20:31
- 2023-08-28 23:39
- 2023-08-08 21:35
- 2023-08-03 02:40
Page 1 of 1
previousnext